Colorado Medical Director Rule

Written by Angela Bonaguidi, LCSW, LAC, MAC – Chair of the Colorado Chapter COTOD

Colorado Medical Director Rule Effective March 2021, a new rule requiring Colorado Opioid Treatment Programs to have medical directors on premises 40% of the time that the program administers or dispenses medication was implemented. In accordance with legislative declaration and the mandates of the Colorado Administrative Procedure ACT, AATOD’s Colorado chapter (COTOD) formally requested reconsideration and amendment of the rule.

The surprising regulation will undoubtedly increase the cost of providing services and ultimately reduce the availability of coverage (particularly in rural areas) without providing improvement in services. Federal guidelines on medical director oversight are reasonable and sufficient; therefore most states do not have regulations on the physical presence of medical directors. COTOD is actively working with the state and is optimistic that the Colorado lawmakers recognize the rule’s destructive influence on OTP services and will create an amendment.

As supporters of #MedicationAssistedTreatment, we understand the dangers of allowing methadone – a Schedule II narcotic – to be distributed at local pharmacies. 
 
ACT NOW by telling Congress to protect the #OTP standard of care & our communities: https://programnotapill.com/write-congress/ #PNAP

Load More...

#aatod2022 conference


AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram

Stay Connected to AATOD